Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

First Data from the Phase 3 HOPE-B Gene Therapy Trial: Efficacy and Safety of Etranacogene Dezaparvovec (AAV5-Padua hFIX variant; AMT-061) in Adults with Severe or Moderate-Severe Hemophilia B Treated Irrespective of Pre-Existing Anti-Capsid Neutralizing Antibodies

Steven W. Pipe, MD, Michael Recht, MD PhD, Nigel S. Key, MD, Frank W.G. Leebeek, MD PhD, Giancarlo Castaman, MD, Susan U. Lattimore, R.N., Paul Van Der Valk, Kathelijne Peerlinck, MD PhD, Michiel Coppens, MD, Niamh O'Connell, MD PhD, John Pasi, MB, ChB, PhD FRCP, FRCPath, FRCPCH, Peter Kampmann, MD, Karina Meijer, MD PhD, Annette von Drygalski, MD Pharm D, Guy Young, MD, Cedric Hermans, MDMRCP,PhD, Jan Astermark, MD PhD, Robert Klamroth, MD PhD, Richard S. Lemons, MD, Nathan Visweshwar, MD, Shelley Crary, MD MS, Rashid Kazmi, MBBS, Emily Symington, Miguel A. Escobar, MD, Esteban Gomez, MD, Rebecca Kruse-Jarres, MD, Adam Kotowski, MD, Doris Quon, MD PhD, Michael Wang, MD, Allison P. Wheeler, MD, Eileen K Sawyer, PhD, Stephanie Verweij, BSc, Valerie Colletta, MSc, Naghmana Bajma, MD, Robert Gut, MD PhD, Wolfgang A. Miesbach, MD PhD

Blood (2020) 136 (Supplement_2): LBA-6.

https://doi.org/10.1182/blood-2020-143560

Published: 2020

Journal Articles

Utility of Inferior Vena Cava Filter in the Management of Venous Thromboembolism Among Patients with Brain Metastases: A Population-Based Study

Vaibhav Kumar, MBBS,MS, Ann M Brunson, MS, Anjlee Mahajan, MD, Nigel S. Key, MD, Ted Wun, MD

Blood (2020) 136 (Supplement 1): 47–48.

https://doi.org/10.1182/blood-2020-138790

Published: 2020

Journal Articles

Venous Thromboembolism Incidence and Impact on Survival in Patients with Brain Metastases

Vaibhav Kumar, MBBS,MS, Xi Zhou, Benjamin Shiang Wu, MSc,PharmD, Joshua Herb, MD, Tzy-Mey Kuo, Laura Green, Chris D Baggett, PhD, Bradford Jackson, Nigel S. Key, MD, Jennifer L Lund, PhD, Katherine E Reeder-Hayes

Blood (2020) 136 (Supplement 1): 1.

https://doi.org/10.1182/blood-2020-136117

Published: 2020

Journal Articles

Thrombin-Induced Endothelial Cell Damage Is Mitigated By Human Anti-Thrombin III in a Microfluidic Device

William Wulftange, Erdem Kucukal, PhD, Yuncheng Man, Ran An, PhD, Karamoja Monchamp, Olabimpe Olayiwola, MS, Jane A. Little, MD, Nigel S. Key, MD, Umut A. Gurkan, PhD

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-141583

Published: 2020

Journal Articles

Etranacogene Dezaparvovec (AAV5-Padua hFIX variant), an Enhanced Vector for Gene Transfer in Adults with Severe or Moderate-Severe Hemophilia B: Two Year Data from a Phase 2b Trial

Annette von Drygalski, Adam Giermasz, MD PhD, Giancarlo Castaman, MD, Nigel S. Key, MD, Susan U. Lattimore, Frank W.G. Leebeek, MD PhD, Wolfgang A. Miesbach, MD, Michael Recht, MD PhD, Esteban Gomez, MD, Robert Gut, Steven W. Pipe, MD

Blood (2020) 136 (Supplement 1): 13.

https://doi.org/10.1182/blood-2020-139295

Published: 2020

Journal Articles

Effects of Tranexamic Acid Prophylaxis on Bleeding Outcomes in Hematologic Malignancy: The a-TREAT Trial

Terry B. Gernsheimer, MD, Siobhan P Brown, PhD, Darrell J Triulzi, MD, Nigel S. Key, MD, Nahed El Kassar, MD PhD, Heather Herren, RN, MPH, Susanne May, PhD

Blood (2020) 136 (Supplement 1): 1–2.

https://doi.org/10.1182/blood-2020-138920

Published: 2020

Journal Articles

Administration of FFP Repletes and Sustains the Megakaryocyte/Platelet-Derived Factor V Pool To Confer Hemostatic Competence in a Factor V-Deficient Individual.

Beth A. Bouchard, PhD, John Chapin, Nigel S. Key, MD, Paula B. Tracy, PhD

Blood (2005) 106 (11): 1779.

https://doi.org/10.1182/blood.V106.11.1779.1779

Published: 2005

Journal Articles

Proteomic Analysis of Gray Platelet Syndrome by iTRAQ Labelling and Mass Spectroscopy: A Potential New Diagnostic Strategy for Platelet Disorders.

Silvia Perez-Pujol, PhD, Lorraine B. Anderson, PhD, Michael B. Martinez, PhD, LeeAnn Higgins, PhD, James G. White, MD, Gary L. Nelsestuen, PhD, Nigel S. Key, MD

Blood (2005) 106 (11): 2161.

https://doi.org/10.1182/blood.V106.11.2161.2161

Published: 2005

Journal Articles

Pilot Study to Test the Efficacy and Safety of Recombinant Factor VIIa (rFVIIa, NovoSeven™) in the Treatment of Refractory Hemorrhagic Cystitis Following High Dose Chemotherapy.

Aneel A. Ashrani, MD, Don A. Gabriel, MD, James L. Gajewski, MD, Nigel S. Key, MD

Blood (2004) 104 (11): 1136.

https://doi.org/10.1182/blood.V104.11.1136.1136

Published: 2004

Journal Articles

Intravascular Tissue Factor (TF) Is Predominantly Platelet-Associated during the Aplastic Phase of Hematopoietic Stem Cell Transplantation (HSCT).

Marketa Markova, MD, Arne Slungaard, MD, Omer Aras, MD, Jessica L. Hysjulien, BS, Janel Long, BS, Arun Shet, MD, Ronald R. Bach, PhD, Nigel S. Key, MD

Blood (2004) 104 (11): 1928.

https://doi.org/10.1182/blood.V104.11.1928.1928

Published: 2004

NARROW

First Data from the Phase 3 HOPE-B Gene Therapy Trial: Efficacy and Safety of Etranacogene Dezaparvovec (AAV5-Padua hFIX variant; AMT-061) in Adults with Severe or Moderate-Severe Hemophilia B Treated Irrespective of Pre-Existing Anti-Capsid Neutralizing Antibodies

Utility of Inferior Vena Cava Filter in the Management of Venous Thromboembolism Among Patients with Brain Metastases: A Population-Based Study

Venous Thromboembolism Incidence and Impact on Survival in Patients with Brain Metastases

Thrombin-Induced Endothelial Cell Damage Is Mitigated By Human Anti-Thrombin III in a Microfluidic Device

Etranacogene Dezaparvovec (AAV5-Padua hFIX variant), an Enhanced Vector for Gene Transfer in Adults with Severe or Moderate-Severe Hemophilia B: Two Year Data from a Phase 2b Trial

Effects of Tranexamic Acid Prophylaxis on Bleeding Outcomes in Hematologic Malignancy: The a-TREAT Trial

Administration of FFP Repletes and Sustains the Megakaryocyte/Platelet-Derived Factor V Pool To Confer Hemostatic Competence in a Factor V-Deficient Individual.

Proteomic Analysis of Gray Platelet Syndrome by iTRAQ Labelling and Mass Spectroscopy: A Potential New Diagnostic Strategy for Platelet Disorders.

Pilot Study to Test the Efficacy and Safety of Recombinant Factor VIIa (rFVIIa, NovoSeven™) in the Treatment of Refractory Hemorrhagic Cystitis Following High Dose Chemotherapy.

Intravascular Tissue Factor (TF) Is Predominantly Platelet-Associated during the Aplastic Phase of Hematopoietic Stem Cell Transplantation (HSCT).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only